Ropes & Gray represented CCMP Growth Advisors in the transaction, and McGuireWoods represented Combined Caterers. CCMP Growth Advisors, LP (“CCMP Growth”), a growth-oriented middle-market private equity...
CCMP Growth Advisors’ Acquisition of Combined Caterers
Organogenesis Holdings’ $130 Million Private Placement Offering of Series A Convertible Preferred Stock
Ropes & Gray represented Avista Healthcare Partners, while Foley Hoag represented Organogenesis Holdings, Inc. in the transaction. Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine...
1440 Foods’ Acquisition of FITCRUNCH and Bakery Barn
Ropes & Gray represented 1440 Foods in the transaction, and Finn Dixon & Herling represented FITCRUNCH and Bakery Barn. 1440 Foods, a portfolio of sports and...
CAMP4 Therapeutics’ $75 Million IPO
Ropes & Gray represented CAMP4 Therapeutics in the transaction, and Paul Hastings represented the underwriters. CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company, announced...
Biohaven Ltd.’s $287.5 Million Follow-On Offering
Maples and Calder acted as British Virgin Islands counsel to Biohaven Ltd. in the offering, and Sullivan & Cromwell acted as New York counsel and Ropes...
Zenas BioPharma’s $225 Million IPO
Ropes & Gray represented Zenas BioPharma in the transaction, and Cooley represented the underwriters. Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company, announced...
Berkshire Partners’ Investment in Vital Care
Ropes & Gray represented Berkshire Partners in the transaction. Berkshire Partners (“Berkshire”) announced its strategic investment alongside Leonard Green & Partners (“Linden”) in Vital Care, an...
TSG Consumer Partners’ Investment in Summer Fridays
Ropes & Gray represented TSG Consumer Partners in the transaction, and Cooley represented Summer Fridays. TSG Consumer Partners announced its investment in Summer Fridays, a clean,...
Amylyx Pharmaceuticals’ Acquisition of Phase 3-Ready Asset from Eiger BioPharmaceuticals
Ropes & Gray represented Amylyx Pharmaceuticals in the transaction and Sidley Austin represented Eiger BioPharmaceuticals. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (Amylyx) announced the acquisition of a...
Foghorn Therapeutics’ $110 Million Common Stock Offering
Ropes & Gray advised Foghorn Therapeutics Inc. on the offering, and Latham & Watkins advised the underwriters. Foghorn Therapeutics Inc. (Nasdaq: FHTX) (“Foghorn”), a clinical-stage biotechnology...
Dessert Holdings’ Acquisition of Kenny’s Great Pies
Ropes & Gray represented Dessert Holdings in the transaction, and Holland & Knight represented Kenny’s Great Pies. Dessert Holdings®, North America’s premium dessert company, announced that...
Chiesi Group’s Collaboration with Gossamer Bio
Ropes & Gray advised Chiesi Group on the transaction, and Latham & Watkins advised Gossamer Bio. Chiesi Group announced it has entered into a global collaboration...